Spots Global Cancer Trial Database for prognostic factors
Every month we try and update this database with for prognostic factors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients | NCT03462888 | Rhabdomyosarcom... | 15 Years - 25 Years | Centre Oscar Lambret | ||
Evaluating Factors Affecting Survival in Colon and Rectum Cancer | NCT05388513 | Colon Cancer Rectum Cancer | Surgical Resect... | 18 Years - | Umraniye Education and Research Hospital | |
Medullary Colonic Carcinoma | NCT05184153 | Medullary Carci... Prognostic Fact... Survival Analys... | - | University Hospital, Limoges | ||
Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab | NCT01706120 | Ovarian Cancer | Bevacizumab Paclitaxel Carboplatin | 18 Years - | National Cancer Institute, Naples | |
MR Radiomic Features in Prostate Cancer | NCT04219059 | Prostate Cancer | 18 Years - | IRCCS San Raffaele | ||
Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma | NCT05193006 | Peritoneal Mali... | No intervention | 18 Years - 80 Years | Hospices Civils de Lyon | |
A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall | NCT00790244 | Soft Tissue Sar... Non Metastatic ... | doxorubicin , i... doxorubicin, if... doxorubicin, if... doxorubicin, if... | 18 Years - 75 Years | Oslo University Hospital | |
Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLC | NCT03055715 | Non Small Cell ... | 18 Years - 100 Years | Martin-Luther-Universität Halle-Wittenberg | ||
Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer | NCT03410784 | Ovarian Cancer | Pembrolizumab Paclitaxel Carboplatin | 18 Years - | National Cancer Institute, Naples | |
Survival With Patients Treated With Salivary Gland Cancer | NCT05390294 | Salivary Gland ... Salivary Gland ... | Surgical interv... | - | Clinical Center of Vojvodina | |
Evaluating Factors Affecting Survival in Colon and Rectum Cancer | NCT05388513 | Colon Cancer Rectum Cancer | Surgical Resect... | 18 Years - | Umraniye Education and Research Hospital | |
Clinical and Pathological Characteristics as Prognostic Factors in Locally Advanced Cervical Cancer | NCT04537273 | Cervical Cancer | Descriptive and... | 18 Years - | National Institute of Cancerología | |
Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis | NCT06206083 | Endometrial Can... | Descriptive and... | 18 Years - | National Institute of Cancerología | |
ACTIVPROSEIN : Professional Activity After Breast Cancer | NCT06025604 | Breast Cancer F... Return to Work | 18 Years - 60 Years | University Hospital, Grenoble | ||
Predictors and Prognostic Factors of Myasthenia Gravis Outcome | NCT05214612 | Myasthenia Grav... Autoimmune Dise... Neuromuscular J... Thymoma Thymus Hyperpla... Nervous System ... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... | Drug treatment ... | 16 Years - | Assiut University | |
A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall | NCT00790244 | Soft Tissue Sar... Non Metastatic ... | doxorubicin , i... doxorubicin, if... doxorubicin, if... doxorubicin, if... | 18 Years - 75 Years | Oslo University Hospital | |
Asian Myeloproliferative Neoplasm (MPN) Registry | NCT05882773 | Myeloproliferat... Polycythemia Ve... Essential Throm... Post-polycythem... Post-essential ... Primary Myelofi... Primary Myelofi... Primary Myelofi... | 18 Years - | The University of Hong Kong | ||
Swedish Oesophago-Gastric Study | NCT05540119 | Oesophageal Can... Gastric Cancer Surgical Treatm... Aetiology Prognostic Fact... Survival Prediction Treatment | Surgery | - | Karolinska Institutet | |
Improving Prenatal Parental Counseling in Cases of Sacrococcygeal Teratoma | NCT04623658 | Sacrococcygeal ... | - 10 Years | Assistance Publique - Hôpitaux de Paris | ||
Ovarian Clear Cell Adenocarcinoma Review | NCT02129036 | Ovarian Cysts | 30 Years - 70 Years | Cathay General Hospital | ||
MR Radiomic Features in Prostate Cancer | NCT04219059 | Prostate Cancer | 18 Years - | IRCCS San Raffaele | ||
Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma | NCT05193006 | Peritoneal Mali... | No intervention | 18 Years - 80 Years | Hospices Civils de Lyon | |
Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy | NCT01151358 | Follicular Lymp... | 18 Years - | University Hospital, Saarland | ||
Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma. | NCT03843905 | Colorectal Neop... Microbiota Prognosis Metabolic Syndr... Sarcopenia | no intervention | 18 Years - | University Hospital, Clermont-Ferrand | |
Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer | NCT01322893 | Metastatic Brea... | 18 Years - | Lund University Hospital | ||
Ovarian Clear Cell Adenocarcinoma Review | NCT02129036 | Ovarian Cysts | 30 Years - 70 Years | Cathay General Hospital | ||
ACTIVPROSEIN : Professional Activity After Breast Cancer | NCT06025604 | Breast Cancer F... Return to Work | 18 Years - 60 Years | University Hospital, Grenoble | ||
Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy | NCT01151358 | Follicular Lymp... | 18 Years - | University Hospital, Saarland | ||
Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML) | NCT03410407 | Acute Myeloid L... | Observation of ... | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer | NCT01322893 | Metastatic Brea... | 18 Years - | Lund University Hospital |